Table 4.
Clinical trials investigating immunotherapy in combination with dietary modifications
Trial no. | Phase | Cancer type | Intervention | Sponsor/investigator |
---|---|---|---|---|
NCT03192059 | II | Cervical/uterine | Pembrolizumab + RT + immunomodulatory cocktail + dietary supplement (curcumin) | University Hospital, Ghent |
NCT03700437 | – | NSCLC | Carboplatin/pemetrexed + pembrolizumab, fasting-mimicking diet | Indiana University |
RT, radiation therapy; NSCLC, non-small cell lung cancer.